ZYBERNO
Stock Report
Updated Sep 1, 2026

ACLARION, INC. (ACON)

Healthcare • NASDAQ

$2.32

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
24.0/100
POOR BUSINESS
ACLARION, INC. (ACON) scores 24/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-59.3%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (-11,592.3%)
Return on Capital (Capital Efficiency):CRITICAL (-1,015.4%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

ACLARION, INC. (ACON) stock report — Zyberno Score 24/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:2.32
Market Cap:$5.71M

Valuation Multiples (3)

P/B Ratio:0.34x
P/S Ratio:68.19x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:-$10.57M

Price Action & Momentum (3)

Momentum Percentile:5 / 100
% of 52-Week High:19.3%
B. Profitability Assessment

Return Metrics (5)

ROA:-56.1%
Reinvestment Rate:2.8%
Fundamental Growth Rate (g):-28.7%

Margin Analysis (3)

Operating Margin Ttm:-11,592.3%
Net Margin Ttm:-10,978.6%
Ebitda Margin:-11,108.6%

TTM Performance (3)

Gross Margin Ttm:21.8%
Operating Margin Ttm:-11,592.3%
Net Margin Ttm:-10,978.6%

Yield Metrics (2)

Earnings Yield:-$653.25
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:69.1%
Latest Earnings Filed:2026-08-06

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):2.0%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:16.20x
Quick Ratio:16.20x
Cash Ratio:15.71x

Leverage Analysis (3)

Debt To Equity Ttm:0.00x
Debt-to-Equity Ratio:0.00x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-7.48x
Times Interest Earned:-7.48

Capital Structure (4)

Working Capital:15,757,274.00
Cash And Cash Equivalents:16,285,462.00
Long Term Debt:$0.00
Net Debt:-$16.29M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $83.77K
Linear Growth: 2.0%
📊 Click to view full ACON Revenue analysis & methodology →
Cost Of Revenue Ttm:$65.55K

Profitability Breakdown (2)

Gross profit TTM: $18.22K
Linear Growth: 46.2%
📊 Click to view full ACON Gross Profit analysis & methodology →
-$9.71M

Bottom Line Performance (3)

-$9.20M
Income Before Tax:-$9.20M
Ebitda Ttm:-9,305,437.00

Operating Expenses (5)

Operating Expenses:9,728,844.00
R And D Expense:1,177,652.00
Sga Expense:5,510,986.00
Income Tax Expense:$0.00
Interest Expense:942,732.00

Expense Ratios (3)

R And D To Revenue Percentage:4,671.7%
Sga To Revenue Percentage:21,862.1%
Ebitda Margin:-11,108.6%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$18.04M
Current Assets:$16.79M
Ppe Net:23,233.00
Goodwill:0.00
Intangible Assets:$1.22M

Liability Structure (4)

Total Liabilities:1,036,934.00
Current Liabilities:1,036,934.00
Long Term Debt:$0.00
Short Term Debt:$0.00

Equity & Capital (3)

Equity:$17.00M
Retained Earnings:-$64.10M
Common Stock:200,000,000.00

Working Capital Items (3)

Accounts Receivable:28,172.00
Inventory:0.00
Accounts Payable:704,979.00

Special Items (2)

Contract Liabilities:13,597.00
Stock Based Compensation:102,117.00
C. Cash Flow Analysis

Operating Activities (2)

-$7.30M-$7.19M

Investment Activities (1)

Investing Cash Flow:-$49.35K

Financing Activities (3)

Financing Cash Flow:$9.68M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:10,400,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:405,184.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-16.07
-$16.07
Earnings Per Share Ttm:-$3.74

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.03
Operating Cash Flow Per Share:-$2.91

Book Value & Capital (2)

Book Value Per Share:$6.91
Cash Per Share:6.61

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.01x
Working Capital Turnover Ttm:0.01x

Receivables Management (2)

Receivables Turnover Ttm:2.97x
Days Sales Outstanding Ttm:122.75

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:3,925.81
Cash Conversion Cycle:-4,802.06
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:2.8%
Fundamental Growth Rate (g):-28.7%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):2.0%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):46.2%
Book Value Growth Rate (Linear):100.0%
C. Company Profile & Context

Corporate Information (6)

Symbol:ACON
Company Name:ACLARION, INC.
Sector:Healthcare
Industry:Services-Medical Laboratories
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:2.46M
Shares Outstanding Basic:2.46M
Shares Outstanding Diluted:2.46M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 16:37:03 UTC
Data Timestamp:2026-08-21T20:46:37.802860
Scroll to Top